FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy

“Mind­Maze, a leader in brain­tech, has today announced that it has obtained FDA clear­ance to launch its portable neu­rore­ha­bil­i­ta­tion prod­uct, Mind­Mo­tion™ GO, in the Unit­ed States.

Read more: https://sharpbrains.com/blog/2018/06/13/fda-clears-mindmaze-go-neurorehabilitation-platform-easing-access-to-continued-outpatient-therapy/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s